TAMPA, Fla.--(BUSINESS WIRE)--Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) announces scientists at Mayo, working under a collaborative agreement with Nanobac Pharmaceuticals Inc., have published an article in the Journal of Investigative Medicine regarding successfully isolating nanoparticles from human kidney stones in cell cultures. The Mayo scientists also isolated proteins, RNA and DNA that appear to be associated with the nanoparticles or CNPs.
